Granules India Ltd Share Price
SECTOR : Pharmaceuticals | BSE :532482 | NSE : GRANULES
Aug 12, 2022 04:01 PM
Pharmaceuticals firm Granules India declares Q4FY22 result:
Commenting on the results, Dr Krishna Prasad Chigurupati, Chairman & Managing Director of Granules India Limited said, “FY 22 has been a challenging year for the industry in the face of adverse external environment with headwinds around the availability and price for Raw Materials, Solvents, Catalysts, uncertainties arising out of Ukraine-Russia conflict as well as reemergence of Covid cases in China. The global supply chain and logistics continue to remain under duress. In face of these challenges, Granules has demonstrated great resilience and I am happy with the performance of the Company. While we strive for continued improvement in our financial performance in the short term, we are working on long term strategy for making ourselves self-sustainable and overcome most of the challenges that we are facing now. We are now embarking on a new journey to reimagine our business model and transform Granules to an Innovative, science & technology driven organization, with responsible sustainable operations.”
Date | Action Type | Ratio |
---|---|---|
Jul 19, 2022 | Dividend | 75 |
Feb 17, 2022 | Dividend | 25 |
Nov 24, 2021 | Dividend | 25 |
Second Floor Block III, My Home Hub Madhapur, Hyderabad, Telangana, 500081
Tel | : | 91-40-66760000 |
: | investorrelations:granulesindia.com | |
Website | : | http://www.granulesindia.com |
CIL Securities Limited
AGM Date (Month) | : | Sep |
Face Value Equity Shares | : | 1 |
Market Lot Equity Shares | : | 1 |
BSE Code | : | 532482 |
NSE Code | : | GRANULES |
Book Closure Date (Month) | : | Jul/Aug |
BSE Group | : | A |
ISIN | : | INE101D01020 |